Suresh Balu

  • Citations Per Year
Learn More
This work presents a head-motion-parallax visualization system for arbitrarily complex computer graphics databases (such as biomedical data sets) using precomputed images. It features a large rear-projection screen and a blind restricting the range of possible vantage points. We describe implementation details for the high-resolution low-lag prototype(More)
The live cell image is transformed into gray image scale, is called the Signal channel noise ratio,that is controlled by using a Block Singular Value Decomposition, and the de noised pixels will be sent to the another medium for refining the signals in the original image,then the refined Signal will be sent to the database for notifying the updating in the(More)
The pharmaceutical industry is shifting its focus from blockbuster small molecules to specialty pharmaceuticals. Specialty pharmaceuticals are novel drugs and biologic agents that require special handling and ongoing monitoring, are administered by injection or infusion, and are sold in the marketplace by a small number of distributors. They are frequently(More)
Signed in 2009, the Health Information Technology for Economic and Clinical Health Act infused $28 billion of federal funds to accelerate adoption of electronic health records (EHRs). Yet, EHRs have produced mixed results and have even raised concern that the current technology ecosystem stifles innovation. We describe the development process and report(More)
in blood cholesterol levels. Specif­ ically, the FDA approved aliro­ cumab as an “adjunct to diet and maximally tolerated statin ther­ apy for the treatment of adults with heterozygous familial hyper­ cholesterolemia or clinical athero­ sclerotic cardiovascular disease, who require additional lowering of LDL [low­density lipoprotein]­ cholesterol.”1 This(More)
  • 1